Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zybrestat combretastatin A4P: Phase II data

In the first stage of an open-label, U.K. Phase II trial,

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE